Publications by authors named "M Debaudringhien"
Article Synopsis
- The study focused on female patients of childbearing age with desmoid-type fibromatosis (DF) to evaluate the impact of hormonal contraception and pregnancy on disease outcomes, specifically event-free survival (EFS).
- Out of 242 patients, results indicated that those who experienced pregnancy had a higher risk of disease progression or relapse within 24 months (hazard ratio of 2.09), but hormonal contraception did not show a significant correlation with these risks.
- The findings suggest that recent pregnancy may increase the risk of progression in DF, while the use of hormonal contraception (both estrogen-progestin and progestin) was not linked to changes in disease outcomes.
